On February 26, 2018, AMCP joined 11 organizations in letter to the OIG in support of establishing a safe harbor provision that would encourage the development of additional value-based contracts for the Medicare and Medicaid populations.
The Academy of Managed Care Pharmacy (AMCP) is writing to express concerns with specific provisions of Assembly Bill 679 and Senate Bill 575. This legislation would regulate biological products and substitution of interchangeable biological products when dispensed by pharmacists.
Press Release: Academy of Managed Care Pharmacy (AMCP) CEO Susan A. Cantrell, RPh, CAE, issued the following statement on President Trump’s budget proposal for fiscal year 2019.
AMCP CEO Blog: The FDA approved 46 novel drugs in 2017, a 21-year high. However, it could take as long as six months for some of these groundbreaking medicines to reach patients.
Press Release: The Biologics and Biosimilars Collective Intelligence Consortium is pleased to announce that Cate Lockhart, PharmD, PhD, has been appointed BBCIC Program Director.